These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922 [TBL] [Abstract][Full Text] [Related]
5. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival. Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610 [TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of krUppel-like factor 6 protein in colorectal cancers. Cho YG; Choi BJ; Song JW; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS World J Gastroenterol; 2006 Apr; 12(14):2250-3. PubMed ID: 16610031 [TBL] [Abstract][Full Text] [Related]
7. KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma. Teixeira MS; Camacho-Vanegas O; Fernandez Y; Narla G; DiFeo A; Lee B; Kalir T; Friedman SL; Schlecht NF; Genden EM; Urken M; Brandwein-Gensler M; Martignetti JA Int J Cancer; 2007 Nov; 121(9):1976-1983. PubMed ID: 17621627 [TBL] [Abstract][Full Text] [Related]
8. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Pandya AY; Talley LI; Frost AR; Fitzgerald TJ; Trivedi V; Chakravarthy M; Chhieng DC; Grizzle WE; Engler JA; Krontiras H; Bland KI; LoBuglio AF; Lobo-Ruppert SM; Ruppert JM Clin Cancer Res; 2004 Apr; 10(8):2709-19. PubMed ID: 15102675 [TBL] [Abstract][Full Text] [Related]
9. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment. Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366 [TBL] [Abstract][Full Text] [Related]
10. A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. Slavin DA; Koritschoner NP; Prieto CC; López-Díaz FJ; Chatton B; Bocco JL Oncogene; 2004 Oct; 23(50):8196-205. PubMed ID: 15378003 [TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression. Marrero-Rodríguez D; Taniguchi-Ponciano K; Jimenez-Vega F; Romero-Morelos P; Mendoza-Rodríguez M; Mantilla A; Rodriguez-Esquivel M; Hernandez D; Hernandez A; Gomez-Gutierrez G; Muñoz-Hernandez N; la Cruz HA; Vargas-Requena C; Díaz-Hernández C; Serna-Reyna L; Meraz-Rios M; Bandala C; Ortiz-Leon J; Salcedo M Tumour Biol; 2014 Nov; 35(11):11399-407. PubMed ID: 25119587 [TBL] [Abstract][Full Text] [Related]
12. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression. Park SS; Kim SW Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359 [TBL] [Abstract][Full Text] [Related]
13. Mutations and Krüppel-like factor 6 (KLF6) expression levels in breast cancer. Ozdemir F; Koksal M; Ozmen V; Aydin I; Buyru N Tumour Biol; 2014 Jun; 35(6):5219-25. PubMed ID: 24519062 [TBL] [Abstract][Full Text] [Related]
14. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines. Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140 [TBL] [Abstract][Full Text] [Related]
15. Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. Hartel M; Narla G; Wente MN; Giese NA; Martignoni ME; Martignetti JA; Friess H; Friedman SL Eur J Cancer; 2008 Sep; 44(13):1895-903. PubMed ID: 18691883 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors]. Zhang Z; Xu G; Liu S Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):287-9. PubMed ID: 11038761 [TBL] [Abstract][Full Text] [Related]
17. KLF6 inhibits estrogen receptor-mediated cell growth in breast cancer via a c-Src-mediated pathway. Liu J; Du T; Yuan Y; He Y; Tan Z; Liu Z Mol Cell Biochem; 2010 Feb; 335(1-2):29-35. PubMed ID: 19707857 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer. Hori M; Shimazaki J; Inagawa S; Itabashi M; Hori M Breast Cancer Res Treat; 2002 Jan; 71(1):77-83. PubMed ID: 11859876 [TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic significance of Krüppel-like transcription factor 6 expression in 67 patients with cutaneous malignant melanoma in China. Zhang N; Qiu LY; Yang F; Gao W; Ma WY; Zhang M Pol J Pathol; 2021; 72(3):245-251. PubMed ID: 35048637 [TBL] [Abstract][Full Text] [Related]
20. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]